eli lilly compounded tirzepatide launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Impurity in Some Compounded Tirzepatide

Exenatide was well tolerated in patients and rates of hypoglycemia were relative low in these studies

FormBlends stands out for 503A pharmacy sourcing and transparent pricing

Eli Lilly, which makes Zepbound and Mounjaro, just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most effective weight loss medication

This hormone plays multiple roles in glucose regulation and appetite control

Pretreatment with GLP-1 receptor antagonist reduced labeled GLP-1 or exendin-4 enrichment in the brain

Measurable weight loss often starts around weeks three to four, with more consistent fat loss developing by weeks five to eight